Non-muscle Invasive Bladder Cancer
Important Message About the BCG Shortage Bacillus Calmette-Guérin (BCG) is a standard treatment option for non-muscle invasive bladder cancer. Merck & Co., the only maker and supplier of BCG to the United States, has informed the Urology Care Foundation that they are now experiencing a global shortage of BCG due the growing use and need […]
Non-muscle Invasive Bladder Cancer Read More »